Prognostic Factors for Recurrence-Free Survival
| Multivariate analysis | |||
| Variable | Univariate analysis, P | P | Hazard ratio |
| Age (≤60 vs. >60 y) | 0.07 | ||
| Sex | 0.7 | ||
| Tumor location | 0.9 | ||
| Tumor size (≤5 vs. >5 cm) | <0.0001 | 0.07 | |
| T stage (T2 vs. T3–4) | <0.0001 | 0.03 | 1.86 (1.07–3.25) |
| Lymph node metastasis | <0.0001 | 0.01 | 3.15 (1.27–7.83) |
| Lymphovascular invasion | <0.0001 | 0.03 | 1.49 (1.05–2.12) |
| Pathology | 0.4 | ||
| Lauren (intestinal vs. nonintestinal) | 0.1 | ||
| Bormann (type 1–3 vs. type 4) | 0.01 | 0.02 | 1.57 (1.06–2.33) |
| Adjuvant treatment | 0.0002 | 0.6 | |
| TLR (≤2.0 vs. >2.0) | <0.0001 | 0.03 | 1.63 (1.04–2.56) |
Data in parentheses are 95% CIs.